Next-Generation Sequencing in Tumor Diagnosis and Treatment
- PMID: 33212911
- PMCID: PMC7698429
- DOI: 10.3390/diagnostics10110962
Next-Generation Sequencing in Tumor Diagnosis and Treatment
Abstract
Next-Generation Sequencing (NGS) allows for the sequencing of multiple genes at a very high depth of coverage [...].
Conflict of interest statement
Matteo Fassan received research grants from Astellas Pharma and QED (Quod Erat Demonstrandum) Therapeutics and reports personal fees (as a speaker or advisor to Astellas Pharma, GlaxoSmithKline (GSK), Diaceutics and Tesaro), which are unrelated to the current work. Umberto Malapelle reports personal fees (as a speaker or advisor) from Boehringer Ingelheim, AstraZeneca, Roche, MSD (Merck Sharp & Dohme), Amgen and Merck, Diaceutics and Eli Lilly, which are unrelated to the current work.
References
-
- Molnar C., Badon E.S., Mokanszki A., Monus A., Beke L., Gyory F., Nagy E., Mehes G. High Genetic Diversity and No Evidence of Clonal Relation in Synchronous Thyroid Carcinomas Associated with Hashimoto’s Thyroiditis: A Next-Generation Sequencing Analysis. Diagnostics. 2020;10:48. doi: 10.3390/diagnostics10010048. - DOI - PMC - PubMed
-
- Chien Y.C., Mokanszki A., Huang H.Y., Geronimo Silva R., Jr., Chen C.C., Beke L., Monus A., Mehes G. First Glance of Molecular Profile of Atypical Cellular Angiofibroma/Cellular Angiofibroma with Sarcomatous Transformation by Next Generation Sequencing. Diagnostics. 2020;10:35. doi: 10.3390/diagnostics10010035. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical